Funds Chase Fringe Assets: Extreme-Duration Treasuries Rally and M&A Heats UpGlobal Report·36 minutes agoVSCO0.00%NIKI-4.76%
The Quiet Corners of Capital: From Preferred Income Havens to Aerospace SolarGlobal Report·1 hour agoXTND-13.43%ASTI+3.64%
Credit and Gold Proxies Highlight Shifting Rate Expectations in 2026Global Report·2 hours agoNIKI-4.76%
Ian Huen named CEO and Alidad Mireskandari named COO of Niki BioSolutionsTradingView·15 hours agoNIKI-4.76%
Aptorum files amended 8-K updating DiamiR Biosciences financial statementsPUBT·Aug 21 at 09:18 PMAPM0.00%NIKI-4.76%
Kira Sheinerman Secures Board Rights at Niki BioSolutions with 51.56% StakeTradingView·Jul 24 at 08:36 PMNIKI-4.76%APM0.00%
Niki BioSolutions falls 9% as gains fade after gene testing dealUS Stock Market Update·Jul 23 at 07:10 PMNIKI-4.76%
Niki BioSolutions falls 5% as early 44% surge fadesUS Stock Market Update·Jul 23 at 05:32 PMNIKI-4.76%
Niki BioSolutions climbs 2% on APOE testing deal after 44% premarket surgeUS Stock Market Update·Jul 23 at 02:00 PMNIKI-4.76%
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga_article·Jul 23 at 12:06 PMSXTC+1.36%HYFT-0.75%
Niki BioSolutions shares are trading higher after the company announced its subsidiary, DiamiR Biosciences, entered into agreement to provide Progressive Medical Research with Apolipoprotein E genotyping services.benzinga_article·Jul 23 at 12:04 PMNIKI-4.76%
Niki BioSolutions Enters into Strategic Agreement to Provide APOE Testing Services for Progressive Medical Research (PMR)Unusual Whales·Jul 23 at 12:03 PMNIKI-4.76%
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga_article·Jul 21 at 05:05 PMTELO0.00%CPHI-2.37%
The Market's Misfits: Who is Faking It and Who is Building the Future?Global Report·Jul 21 at 09:13 AMCSIQ-2.29%AVEX+0.92%